Skip to main content

Site notifications

Celgene Pty Limited

Regulatory activities for this sponsor.

Sponsor content

3 result(s) found, displaying 1 to 3
  • AusPAR for Zeposia (ozanimod) for the treatment of adult patients with moderately to severely active ulcerative colitis.
  • Australian prescription medicine decision summary
  • Australian prescription medicine decision summary

Help us improve the Therapeutic Goods Administration site